Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

PHASE2SuspendedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 1999

Conditions
HIV Infections
Interventions
DRUG

Lamivudine/Zidovudine

DRUG

Capravirine

DRUG

Nelfinavir mesylate

Trial Locations (10)

10014

Liberty Medical, New York

11432

Catholic Med Ctr, Jamaica

15221

Anderson Clinical Research, Pittsburgh

30308

AIDS Research Consortium of Atlanta, Atlanta

33139

South Shore Hosp, Miami

33306

Community Health Care, Fort Lauderdale

33765

Clin Research of West Florida, Clearwater

34239

Infectious Diseases Associates, Sarasota

02215

Beth Israel Deaconess Med Ctr, Boston

Unknown

Immunity Care and Research Inc, Santo Domingo

Sponsors
All Listed Sponsors
lead

Agouron Pharmaceuticals

INDUSTRY

NCT00004998 - Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients | Biotech Hunter | Biotech Hunter